cGAS-STING Innate Immune DNA Sensing
The cGAS-STING pathway is an essential cytosolic DNA-sensing cascade that synthesizes 2'3'-cGAMP to activate STING, TBK1, and IRF3, driving robust type I interferon antiviral responses.
The cGAS-STING signaling pathway is an ancient, evolutionarily conserved cytosolic surveillance system that detects double-stranded DNA (dsDNA) within the cytoplasm of eukaryotic cells. Discovered in 2012 and 2013 by Zhijian "James" Chen and colleagues at UT Southwestern, cyclic GMP-AMP synthase (cGAS) functions as a sequence-independent sensor that converts cytosolic DNA encounters into an enzymatic signal.
Upon binding dsDNA, cGAS synthesizes an unconventional non-canonical cyclic dinucleotide, 2'3'-cGAMP, which acts as an endogenous second messenger. 2'3'-cGAMP diffuses through the cytosol and binds to the endoplasmic reticulum (ER)-resident adaptor protein STING (stimulator of interferon genes). Once activated, STING translocates to the Golgi apparatus and recruits TANK-binding kinase 1 (TBK1), which phosphorylates interferon regulatory factor 3 (IRF3). This triggers nuclear translocation of IRF3 and robust transcription of type I interferons (IFN-ฮฑ and IFN-ฮฒ) and pro-inflammatory cytokines, mounting an immune shield against viral infection and cellular transformation.
cGAS Activation and the Synthesis of 2'3'-cGAMP
Cyclic GMP-AMP synthase (cGAS) belongs to the nucleotidyltransferase family. In the absence of ligand, cGAS adopts a resting, catalytically inactive conformation:
When double-stranded DNA appears in the cytoplasmโarising from DNA viruses, retroviral reverse transcription, intracellular bacteria, or damaged self-nuclei and mitochondriaโtwo cGAS monomers bind to opposite sides of the DNA duplex. This interaction organizes a 2:2 cGAS-dsDNA macromolecular complex:
- Liquid-Liquid Phase Separation: At physiological concentrations, multivalent interactions between cGAS and long dsDNA fragments (typically exceeding 45 base pairs) induce liquid-liquid phase separation (LLPS). The resulting membrane-less liquid micro-droplets concentrate cGAS enzymes and substrate nucleotides (ATP and GTP) while excluding negative regulatory phosphatases, creating an enzymatic microreactor that accelerates catalysis.
- Catalytic Mechanism: DNA binding rearranges the active site catalytic triad (Glu225, Asp227, Asp319 in human cGAS), enabling it to catalyze a two-step cyclization reaction. First, cGAS forms a phosphodiester linkage between the 2'-hydroxyl of GMP and the 5'-phosphate of AMP. In the second step, it completes the ring by forming a standard 3'-5' linkage between the 3'-hydroxyl of AMP and the 5'-phosphate of GMP, producing the unique cyclic dinucleotide cyclic [G(2',5')pA(3',5')p], commonly designated 2'3'-cGAMP.
STING Activation and Golgi Trafficking
The generated 2'3'-cGAMP messenger binds with high nanomolar affinity to the dimeric transmembrane receptor STING anchored in the endoplasmic reticulum:
In resting cells, STING exists as an autoinhibited homodimer with its C-terminal domain exposed to the cytosol. The binding of 2'3'-cGAMP into the central pocket between the two protomers induces a dramatic 180-degree rotational closure of the STING dimer lid:
- This conformational shift promotes the assembly of higher-order STING oligomers and polymers.
- The activated STING oligomers pack into COPII vesicles and exit the endoplasmic reticulum, translocating via the ER-Golgi intermediate compartment (ERGIC) to the Golgi apparatus.
Kinase Recruitment, Phosphorylation, and Gene Transcription
At the Golgi membrane, polymerized STING undergoes post-translational modifications (including palmitoylation at Cys88 and Cys91) essential for downstream signaling:
- TBK1 Recruitment: Palmitoylated STING oligomers provide a docking platform that recruits the serine/threonine kinase TBK1 (TANK-binding kinase 1). Clustered TBK1 molecules undergo trans-autophosphorylation, becoming fully active.
- IRF3 Activation: Active TBK1 phosphorylates the conserved C-terminal tail of STING, creating a specific binding motif for the transcription factor IRF3 (interferon regulatory factor 3). TBK1 then phosphorylates recruited IRF3 monomers, prompting IRF3 to dimerize and dissociate from STING.
- Nuclear Translocation: Dimerized IRF3 translocates to the nucleus, where it binds to interferon-stimulated response elements (ISRE), driving massive transcription of type I interferon genes (IFNA, IFNB1) and dozens of interferon-stimulated genes (ISGs).
- NF-ฮบB Activation: Concurrently, STING recruits the IฮบB kinase (IKK) complex, triggering phosphorylation of IฮบBฮฑ and nuclear translocation of NF-ฮบB (p50/p65), inducing the expression of interleukin-6 (IL-6) and tumor necrosis factor (TNF).
Following signaling, STING is sorted into multivesicular endosomes and delivered to lysosomes for degradation, ensuring the signal is extinguished to prevent lethal autoinflammation.
Roles in Tumor Immunity and Cancer Immunotherapy
Beyond its classical antimicrobial role, the cGAS-STING axis serves as a primary sentinel of cellular genomic instability and tumor immunity:
- Sensing Micronuclei and Chromothripsis: Malignant tumor cells frequently undergo defective mitosis, generating chromosomal fragments encapsulated within fragile extranuclear structures called micronuclei. When micronuclear envelopes rupture, cGAS binds the exposed genomic DNA, triggering type I interferon secretion.
- Dendritic Cell Cross-Priming: Tumor-derived DNA or 2'3'-cGAMP is engulfed by tumor-infiltrating dendritic cells (DCs). Activation of STING within DCs stimulates the expression of costimulatory molecules (CD80, CD86) and cross-presents tumor neoantigens to CD8+ cytotoxic T lymphocytes.
- Therapeutic STING Agonists: Pharmaceutical companies have synthesized synthetic non-hydrolyzable cyclic dinucleotides (such as ADU-S100) and small-molecule oral STING agonists to convert immunologically "cold" tumors into inflamed "hot" lesions, enhancing the therapeutic efficacy of anti-PD-1 checkpoint blockade.
Pathological Autoinflammation: SAVI and Aicardi-Goutiรจres Syndrome
Constitutive, uncontrolled activation of the cGAS-STING axis causes severe autoinflammatory diseases:
- STING-Associated Vasculopathy with Onset in Infancy (SAVI): Caused by de novo gain-of-function point mutations in STING1 (such as V155M or N154S), SAVI results in ligand-independent constitutive STING dimerization and spontaneous Golgi trafficking, producing severe cutaneous vasculitis, gangrene, and interstitial lung fibrosis.
- Aicardi-Goutiรจres Syndrome (AGS): Loss-of-function mutations in the 3' repair exonuclease 1 (TREX1) gene prevent the clearance of endogenous cytosolic retrotransposons and replication byproducts. Accumulated self-DNA hyperactivates cGAS, driving lethal infantile encephalopathy and cerebral microangiopathy.
References
- Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013). Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science, 339(6121), 786-791. doi:10.1126/science.1232458
- Wu, J., Sun, L., Chen, X., Du, F., Shi, H., Chen, C., & Chen, Z. J. (2013). Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science, 339(6121), 826-830. doi:10.1126/science.1229963
- Barber, G. N. (2015). STING: infection, inflammation and cancer. Nature Reviews Immunology, 15(12), 760-770. doi:10.1038/nri3921